Heartflow Documents
Documents
60
Ticker
HTFL
ISIN
US42238D1072
Heartflow SEC Filings
Heartflow Documents 2026
This page contains all official documents and SEC filings for Heartflow stock (HTFL, ISIN: US42238D1072). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 60 documents are available. Data is updated regularly to provide investors with a complete overview of Heartflow's regulatory filings.
Heartflow Stock analysis
Heartflow Heartflow Inc generates revenue through its HeartFlow Platform, which includes AI-driven software solutions for diagnosing coronary artery disease. The company's products, such as HeartFlow FFRCT Analysis and Plaque Analysis, assist physicians in managing patient care by providing personalized 3D heart models derived from CCTA scans. These tools are sold to healthcare providers and hospitals, enabling non-invasive diagnosis and treatment planning for coronary artery disease. The RoadMap Analysis offers intuitive visualization of coronary arteries, helping physicians focus on critical areas during patient reviews. The HeartFlow Platform leverages artificial intelligence and computational fluid dynamics to create detailed cardiac models, positioning Heartflow Inc as a leader in medical technology for cardiovascular diagnostics. Its commercial-stage operations focus on delivering precision care solutions that improve diagnostic accuracy and patient outcomes. Healthcare institutions purchase these AI-powered tools to enhance their diagnostic capabilities without invasive procedures.